FIELD: medicine. SUBSTANCE: method involves detecting presence of mycoflora on open and closed areas of healthy skin. Material is taken by applying imprinting method in two points on front skin and on skin above the lower half of the breast bone. When found on healthy areas of skin, fungi prove immune deficiency to be the case. EFFECT: simplified method; no blood samples are taken. 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSIS OF IMMUNODEFICIENCY WITH HIV-INFECTION | 1997 |
|
RU2134879C1 |
| METHOD TO PREDICT CANDIDOSIS AT HIV-INFECTION | 1995 |
|
RU2109289C1 |
| METHOD OF CRYPTOCOCCEMIA DIAGNOSIS | 1995 |
|
RU2090616C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME IN CLINICAL COURSE OF COINFECTION OF HIV AND TUBERCULOSIS, ACCOMPANIED BY MULTIPLE DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2019 |
|
RU2710266C1 |
| USE OF INACTIVATED INTACT VIRUS OF COMPATIBLE SUBTYPE TO OBTAIN ACELLULAR VACCINE AND METHOD OF TREATING HIV INFECTION | 2005 |
|
RU2396346C2 |
| METHOD OF PREDICTING PROGRESSION OF HIV INFECTION IN PATIENTS RECEIVING ANTIRETROVIRAL THERAPY | 2019 |
|
RU2697392C1 |
| METHOD FOR PREDICTING PROGRESSIVE LIVER FIBROSIS AND SELECTING A COMBINATION OF PREPARATIONS FOR ANTIRETROVIRAL THERAPY IN CO-INFECTION OF HIV/HCV | 2018 |
|
RU2705570C1 |
| DS-IFA-VICH-AT-SROK ENZYME IMMUNOASSAY SYSTEM FOR DETERMINING PROBABLE TIME OF INTRODUCTION OF TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) INFECTION, INCLUDING GROUP O HIV-1 IN HUMAN SERUM (PLASMA) | 2013 |
|
RU2515051C1 |
| METHOD FOR PREDICTING THE STAGES OF HIV-INFECTION | 2004 |
|
RU2251701C1 |
| METHOD OF PREDICTING EFFICIENCY OF ANTIRETROVIRAL THERAPY IN CASE IN HIV-INFECTION | 2009 |
|
RU2414858C1 |
